Pediatric Epilepsy Study

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Epilepsy
Interventions
DRUG

oxcarbazepine

Trial Locations (30)

10016

New York

14222

Buffalo

15213

Pittsburgh

19104

Philadelphia

24105

Kiel

27607

Raleigh

29303

Spartenberg

30342

Atlanta

33155

Miami

33607

Tampa

35233

Birmingham

36693

Mobile

44106

Cleveland

44308

Akron

45229

Cincinnati

48109

Ann Arbor

55102

Saint Paul

55805

Duluth

63017

Chesterfields

63110

St Louis

76104

Fort Worth

77030

Houston

77694

Kehl-Kork

80218

Denver

92868

Orange

93638

Madera

97201

Portland

01401-901

Brigadeiro Hospital, Sao Paulo - SP

07740

Jena

Unknown

Novartis, Mexico City

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY